2抑制剂-话题@MedSci

#2抑制剂#

221篇内容 | 4048人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995477, encodeId=b6fa19954e7b7, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, objectType=article, longId=60556, objectId=f8216055671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8216055671, replyNumber=0, likeNumber=101, createdTime=2016-10-26, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8216055671, moduleTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8216055671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995474, encodeId=142319954e45c, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=郭艺芳：SGLT-2抑制剂——具有降糖作用的降压药, objectType=article, longId=60091, objectId=38b0600912e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38b0600912e, replyNumber=0, likeNumber=77, createdTime=2015-12-07, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38b0600912e, moduleTitle=郭艺芳：SGLT-2抑制剂——具有降糖作用的降压药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38b0600912e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995480, encodeId=27781995480de, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Aliment Pharmacol Ther：选择性COX-2抑制剂+PPIs可显著降低NSAID相关胃肠道毒性风险, objectType=article, longId=68745, objectId=261268e45c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261268e45c0, replyNumber=0, likeNumber=109, createdTime=2016-12-28, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261268e45c0, moduleTitle=Aliment Pharmacol Ther：选择性COX-2抑制剂+PPIs可显著降低NSAID相关胃肠道毒性风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=261268e45c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995476, encodeId=97e919954e6e4, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）, objectType=article, longId=60553, objectId=902360553c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=902360553c9, replyNumber=0, likeNumber=79, createdTime=2016-02-25, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=902360553c9, moduleTitle=CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=902360553c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995475, encodeId=329b19954e5f1, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=FDA警告：糖尿病治疗新秀“SGLT2抑制剂”导致酮症酸中毒风险, objectType=article, longId=60331, objectId=8b316033177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b316033177, replyNumber=0, likeNumber=105, createdTime=2015-12-12, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b316033177, moduleTitle=FDA警告：糖尿病治疗新秀“SGLT2抑制剂”导致酮症酸中毒风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b316033177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995472, encodeId=503d19954e2da, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JCI：炎症疾病治疗新靶点--UCP2抑制剂有望治疗败血症, objectType=article, longId=45364, objectId=988945364f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=988945364f6, replyNumber=0, likeNumber=61, createdTime=2015-04-16, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=988945364f6, moduleTitle=JCI：炎症疾病治疗新靶点--UCP2抑制剂有望治疗败血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=988945364f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995470, encodeId=aaf119954e033, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Circulation：连接COX-2抑制剂&心血管功能障碍的桥梁---ADMA（一氧化氮合成酶抑制剂）, objectType=article, longId=44229, objectId=b97b4422963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97b4422963, replyNumber=0, likeNumber=71, createdTime=2015-05-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97b4422963, moduleTitle=Circulation：连接COX-2抑制剂&心血管功能障碍的桥梁---ADMA（一氧化氮合成酶抑制剂）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97b4422963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995471, encodeId=5f3f19954e1be, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=J Natl Cancer Inst：肺癌治疗的独特选择:解析COX-2抑制剂的应用, objectType=article, longId=45037, objectId=adab4503e1d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adab4503e1d, replyNumber=0, likeNumber=71, createdTime=2015-10-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adab4503e1d, moduleTitle=J Natl Cancer Inst：肺癌治疗的独特选择:解析COX-2抑制剂的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adab4503e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995468, encodeId=4c3c19954682e, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance, objectType=article, longId=39710, objectId=b27f39e10a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b27f39e10a3, replyNumber=0, likeNumber=97, createdTime=2015-04-27, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b27f39e10a3, moduleTitle=礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b27f39e10a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995467, encodeId=e03f199546e55, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes：二甲双胍和SGLT2抑制剂组合有效降低血糖水平, objectType=article, longId=38740, objectId=f8ca38e4040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ca38e4040, replyNumber=0, likeNumber=79, createdTime=2014-09-18, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ca38e4040, moduleTitle=Diabetes：二甲双胍和SGLT2抑制剂组合有效降低血糖水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ca38e4040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995469, encodeId=9a451995469e9, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Neurology：COX-2抑制剂与中风死亡率升高相关, objectType=article, longId=42421, objectId=c8b54242162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8b54242162, replyNumber=0, likeNumber=77, createdTime=2015-10-20, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8b54242162, moduleTitle=Neurology：COX-2抑制剂与中风死亡率升高相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8b54242162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995465, encodeId=95541995465fa, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Care：SGLT-2抑制剂Empagliflozin添加胰岛素控制不佳的肥胖T2DM患者取得较好疗效（EMPA-REG MDI研究）, objectType=article, longId=36771, objectId=40bf36e716f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40bf36e716f, replyNumber=0, likeNumber=41, createdTime=2015-03-25, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40bf36e716f, moduleTitle=Diabetes Care：SGLT-2抑制剂Empagliflozin添加胰岛素控制不佳的肥胖T2DM患者取得较好疗效（EMPA-REG MDI研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40bf36e716f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995466, encodeId=81f91995466ad, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Diabetes Obes Metab：新型SGLT2抑制剂疗效获日本研究肯定, objectType=article, longId=38001, objectId=86f838001c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86f838001c8, replyNumber=0, likeNumber=35, createdTime=2015-06-20, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86f838001c8, moduleTitle=Diabetes Obes Metab：新型SGLT2抑制剂疗效获日本研究肯定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86f838001c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995463, encodeId=c2b9199546335, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）, objectType=article, longId=26983, objectId=0b5c2698398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b5c2698398, replyNumber=0, likeNumber=82, createdTime=2014-07-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b5c2698398, moduleTitle=JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b5c2698398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995464, encodeId=a89819954648f, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好, objectType=article, longId=27984, objectId=83392e98476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83392e98476, replyNumber=0, likeNumber=93, createdTime=2014-09-15, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83392e98476, moduleTitle=Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83392e98476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995462, encodeId=f12b1995462ef, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=EMA委员会：双氯芬酸的风险与COX-2抑制剂类似, objectType=article, longId=20370, objectId=64db203e0ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64db203e0ce, replyNumber=0, likeNumber=80, createdTime=2014-01-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64db203e0ce, moduleTitle=EMA委员会：双氯芬酸的风险与COX-2抑制剂类似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64db203e0ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995461, encodeId=27bc199546150, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=Carcinogenesis：COX-2抑制剂对肿瘤EMT后更有效, objectType=article, longId=7503, objectId=7ea4e5039f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ea4e5039f, replyNumber=0, likeNumber=84, createdTime=2012-11-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ea4e5039f, moduleTitle=Carcinogenesis：COX-2抑制剂对肿瘤EMT后更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ea4e5039f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995460, encodeId=9053199546018, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=COX-2抑制剂或能预防宫颈癌发病, objectType=article, longId=3921, objectId=2d0f392185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0f392185, replyNumber=0, likeNumber=0, createdTime=2012-12-08, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0f392185, moduleTitle=COX-2抑制剂或能预防宫颈癌发病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d0f392185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995459, encodeId=ce271995459de, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期, objectType=article, longId=3452, objectId=4d983452fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d983452fd, replyNumber=0, likeNumber=78, createdTime=2012-09-14, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d983452fd, moduleTitle=NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d983452fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995457, encodeId=ae2d199545e99, content=<a href='/topic/show?id=992411149e' target=_blank style='color:#2F92EE;'>#2抑制剂#</a>, objectTitle=GUT:选择性COX-2抑制剂单用对胃癌癌前病变有效, objectType=article, longId=3104, objectId=009e310493, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009e310493, replyNumber=0, likeNumber=66, createdTime=2012-05-07, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009e310493, moduleTitle=GUT:选择性COX-2抑制剂单用对胃癌癌前病变有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009e310493)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2抑制剂

2020-05-29

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用

2016-10-26

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

郭艺芳：SGLT-2抑制剂——具有降糖作用的降压药

2015-12-07

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Aliment Pharmacol Ther：选择性COX-2抑制剂+PPIs可显著降低NSAID相关胃肠道毒性风险

2016-12-28

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）

2016-02-25

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

FDA警告：糖尿病治疗新秀“SGLT2抑制剂”导致酮症酸中毒风险

2015-12-12

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

JCI：炎症疾病治疗新靶点--UCP2抑制剂有望治疗败血症

2015-04-16

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Circulation：连接COX-2抑制剂&心血管功能障碍的桥梁---ADMA（一氧化氮合成酶抑制剂）

2015-05-06

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

J Natl Cancer Inst：肺癌治疗的独特选择:解析COX-2抑制剂的应用

2015-10-06

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

礼来SGLT-2抑制剂闪亮登场——勃林格-礼来联盟美国推出降糖新药Jardiance

2015-04-27

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes：二甲双胍和SGLT2抑制剂组合有效降低血糖水平

2014-09-18

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Neurology：COX-2抑制剂与中风死亡率升高相关

2015-10-20

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Care：SGLT-2抑制剂Empagliflozin添加胰岛素控制不佳的肥胖T2DM患者取得较好疗效（EMPA-REG MDI研究）

2015-03-25

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Diabetes Obes Metab：新型SGLT2抑制剂疗效获日本研究肯定

2015-06-20

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）

2014-07-22

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Leukemia：选择性Bcl-2抑制剂ABT-199临床试验证明对白血病疗效良好

2014-09-15

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

EMA委员会：双氯芬酸的风险与COX-2抑制剂类似

2014-01-13

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

Carcinogenesis：COX-2抑制剂对肿瘤EMT后更有效

2012-11-13

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

COX-2抑制剂或能预防宫颈癌发病

2012-12-08

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期

2012-09-14

仁医06 (审核中...)

前往app查看评论内容

#2抑制剂#

GUT:选择性COX-2抑制剂单用对胃癌癌前病变有效

2012-05-07

科室
- - 订阅+
  - 更多科室
工具
服务